ARCHIVES

Steven Woolf: Why CMS Should Not Cover LDCT

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007

NIH Issues Interim Guidelines For Research Using fetal Tissue

March 26, 1993

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000